Earlier this week the U.K. Government announced that the Patent Act would be amended to “allow clinical and field trials and health technology assessment for new drugs to be carried out without running the risk of being sued for patent infringement.”
View the U.K. Government press release, Cutting of red tape to benefit research and development of new drugs, for more information.
By Claire Palmer